Skye Bioscience, Inc.
SKYE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $68,416 | $1,256 | $1,245 | $8,983 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $158 | $74 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,406 | $10,236 | $7,625 | $629 |
| Total Curr. Assets | $70,827 | $11,651 | $8,944 | $9,612 |
| Property Plant & Equip (Net) | $1,883 | $281 | $159 | $235 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $54 | $8 | $8 | $8 |
| Total NC Assets | $1,937 | $290 | $167 | $243 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $72,764 | $11,940 | $9,111 | $9,855 |
| Liabilities | – | – | – | – |
| Payables | $569 | $957 | $1,795 | $900 |
| Short-Term Debt | $182 | $4,444 | $1,983 | $2,057 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,587 | $8,500 | $8,342 | $955 |
| Total Curr. Liab. | $4,339 | $13,901 | $12,119 | $3,912 |
| LT Debt | $273 | $171 | $0 | $79 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $273 | $171 | $0 | $79 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $456 | $243 | $79 | $161 |
| Total Liabilities | $4,612 | $14,072 | $12,119 | $3,991 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $31 | $12 | $4 | $476 |
| Retained Earnings | -$130,950 | -$104,383 | -$66,738 | -$47,256 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $199,070 | $102,238 | $63,726 | $52,644 |
| Total Equity | $68,152 | -$2,132 | -$3,008 | $5,864 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $72,764 | $11,940 | $9,111 | $9,855 |
| Net Debt | -$67,960 | $3,359 | $738 | -$6,847 |